Eden Research plc announced that it has received regulatory approval from the United States Environmental Protection Agency (EPA), for all five petitions submitted, covering the Company's three active ingredients (eugenol, geraniol and thymol) and two formulated products (Mevalone®and Cedroz™). The EPA approval of Eden's products and active ingredients will open significant revenue opportunities for Eden, with total market potential of approximately €94m for Mevalone and €189m for Cedroz. In addition, the Board expects that ultimately the registration of Eden's developmental insecticide will follow a shortened timeline as it is based upon the now-approved active ingredients.

Eden will pursue registration of this new product in due course based upon the outcome of field trials. The total market potential for the insecticide is €237 million. The EPA authorisations are the result of over four years of effort by our experienced regulatory, development and commercial teams who worked tirelessly to ensure that Eden addressed the EPA's extensive and evolving list of strict requirements.